{
    "clinical_study": {
        "@rank": "50255", 
        "arm_group": [
            {
                "arm_group_label": "tDCS simultaneously with hyperbaric oxygen therapy", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "tDCS 3 weeks after start tinnitus", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The treatment for patients with acute tinnitus consists of Methylprednisolone and hyperbaric\n      oxygen therapy. For this study  transcranial direct current stimulation (tDCS) was added to\n      the protocol. The purpose is to determine the effect of the time shift of tDCS. Two\n      conditions will be compared: tDCS simultaneously with the hyperbaric oxygen therapy or tDCS\n      3 weeks after the start of the tinnitus.\n\n      An audiological testing will be performed at the day of admission, after 3 weeks, 6 weeks\n      and 12 weeks."
        }, 
        "brief_title": "Effect of Time Shift of Transcranial Direct Current Stimulation (tDCS) for Treatment of Acute Tinnitus", 
        "condition": "Tinnitus", 
        "condition_browse": {
            "mesh_term": "Tinnitus"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age between 18 and 50 years\n\n          -  presence of acute tinnitus or worsening of tinnitus caused by otogenic disease\n\n          -  registration in UZA within 48 hours after start tinnitus\n\n          -  VAS-score \u2265 4\n\n          -  ability to understand and sign informed consent\n\n        Exclusion Criteria:\n\n          -  history of epileptic seizures\n\n          -  severe organic comorbidity\n\n          -  psychiatric disorders or a history of psychiatric disorders with psychotic symptoms\n\n          -  Pace maker\n\n          -  pregnancy"
            }, 
            "gender": "Both", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "June 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01886729", 
            "org_study_id": "EC 11/18/146"
        }, 
        "intervention": {
            "arm_group_label": [
                "tDCS simultaneously with hyperbaric oxygen therapy", 
                "tDCS 3 weeks after start tinnitus"
            ], 
            "intervention_name": "transcranial direct current stimulation (tDCS)", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "transcranial direct current stimulation", 
            "time shift"
        ], 
        "lastchanged_date": "June 25, 2013", 
        "location": {
            "contact": {
                "email": "sarah.rabau@uza.be", 
                "last_name": "Sarah Rabau", 
                "phone": "003238215235"
            }, 
            "facility": {
                "address": {
                    "city": "Edegem", 
                    "country": "Belgium", 
                    "state": "Antwerp", 
                    "zip": "2650"
                }, 
                "name": "University hospital of Antwerp"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "sarah.rabau@uza.be", 
            "last_name": "Sarah Rabau", 
            "phone": "003238215235"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Belgium: Ethics Committee"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Tinnitus Questionnaire, Visual Analog Scale, Beck Depression Index, Hyperacusis questionnaire", 
            "measure": "Improvement of tinnitus", 
            "time_frame": "12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01886729"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University Hospital, Antwerp", 
            "investigator_full_name": "Ethisch Comit\u00e9 UZ Antwerpen", 
            "investigator_title": "Sarah Rabau", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Audiometry, Otoacoustic emissions, Tympanometry, Speech in noise", 
            "measure": "Hearing", 
            "safety_issue": "Yes", 
            "time_frame": "12 weeks"
        }, 
        "source": "University Hospital, Antwerp", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Antwerp", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}